Very well explained. Good to see management now providing some context with 4C’s - I wonder if they read HC?
Pretty clear that these CV impacts were unavoidable.
It’s still not clear what the impact is on 2021 earnings and sales. Will deferred sales be added to 2021 sales or will some 2021 sales be pushed into 2022 etc
Also, does anyone know if management participated in the CR?
Ann: Appendix 4C - quarterly, page-2
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EOS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.71 |
Change
0.100(6.21%) |
Mkt cap ! $329.9M | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.76 | $1.60 | $3.183M | 1.861M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 94544 | 4 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| EOS (ASX) Chart |